Protagonist Therapeutics
PTGX
PTGX
92 hedge funds and large institutions have $728M invested in Protagonist Therapeutics in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 30 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+7
Holders Change %
+8.24%
% of All Funds
1.86%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
20
Increased
30
Reduced
32
Closed
13
Calls
$1K
Puts
$7K
Net Calls
-$6K
Net Calls Change
-$6K
Top Buyers
Top Sellers
| 1 |
1
Millennium Management
New York
|
$0 |
| 2 |
BBA
2
Baker Bros. Advisors
New York
|
$31.2M |
| 3 |
3
Goldman Sachs
New York
|
$4.34M |
| 4 |
4
D.E. Shaw & Co
New York
|
$10.3M |
| 5 |
5
Renaissance Technologies
New York
|
$6.58M |
